New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis

Minghua Wang1, Qinglan Guo, Xiaogang Xu

  • 1Institute of Antibiotics, Huashan Hospital, Fudan University, 12 M. Wulumuqi Rd., Shanghai 200040, People's Republic of China.

Insights

A novel quinolone resistance gene, qnrC, was identified in a Proteus mirabilis strain. This gene, located on plasmid pHS10, confers low-level quinolone resistance in gram-negative pathogens.

Area of Science:

  • Microbiology
  • Genetics
  • Molecular Biology

Background:

  • Quinolone resistance in gram-negative pathogens is a growing global health concern.
  • Plasmid-mediated quinolone resistance genes (e.g., qnrA, qnrB, qnrS) contribute significantly to this issue.
  • The emergence of new resistance mechanisms necessitates continuous surveillance and characterization.

Purpose of the Study:

  • To identify and characterize novel quinolone resistance genes in clinical isolates.
  • To investigate the genetic basis of quinolone resistance in a Proteus mirabilis strain.
  • To determine the prevalence and genetic environment of newly discovered resistance genes.

Main Methods:

  • Conjugation experiments to transfer resistance plasmids.
  • Polymerase Chain Reaction (PCR) to screen for known resistance genes.
  • Plasmid DNA digestion, cloning, and sequencing to identify novel genes.
  • Bioinformatic analysis to compare the novel gene with known resistance genes.

Main Results:

  • A Proteus mirabilis clinical isolate exhibited resistance to ampicillin, sulfamethoxazole, and trimethoprim, with low-level quinolone resistance.
  • Conjugation of plasmid pHS10 to Escherichia coli J53 resulted in increased ciprofloxacin Minimum Inhibitory Concentration (MIC).
  • Sequencing identified a novel 666-bp gene, designated qnrC, encoding a 221-amino-acid protein with varying homology to other Qnr proteins.
  • A novel insertion sequence, ISPmi1, was found upstream of qnrC.
  • qnrC was not detected by PCR in 2,020 Enterobacteriaceae strains.

Conclusions:

  • A new plasmid-mediated quinolone resistance gene, qnrC, has been identified and characterized.
  • The qnrC gene confers low-level quinolone resistance and is associated with a novel insertion sequence.
  • Further surveillance is needed to understand the prevalence and spread of qnrC in clinical settings.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antibiotic Selection00:57

Antibiotic Selection

Overview